Trimodal Glioblastoma Treatment Consisting of Concurrent Radiotherapy, Temozolomide, and the Novel TGF-β Receptor I Kinase Inhibitor LY2109761

Here we investigate the effects of the novel transforming growth factor-β receptor I (TGF-βRI) serine/threonine kinase inhibitor LY2109761 on glioblastoma when combined with the present clinical standard combination regimen radiotherapy and temozolomide (TMZ). Human GBM U87 (methylated MGMT promoter...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhang, Mengxian, Herion, Tobias W, Timke, Carmen, Han, Na, Hauser, Kai, Weber, Klaus J, Peschke, Peter, Wirkner, Ute, Lahn, Michael, Huber, Peter E
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press Inc. 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3114247/
https://ncbi.nlm.nih.gov/pubmed/21677877
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados